Literature DB >> 28805937

New data on hyperpigmentation disorders.

S Schalka1.   

Abstract

Recently visible light (VL) and vascularization triggered by infrared light (IR) play a role in hyperpigmentation disorders of the skin. The aim of this article is to provide an update on the aetiology of hyperpigmentation disorders and means of prevention against UV, visible (VL) and infrared light (IR). The author conducted a literature review of the most recent data about hyperpigmentation disorders and means of prevention and protection. VL impacts on pigmentation, especially in individuals with phototype III, IV or V and also causes the production of Reactive Oxygen Species (ROS), erythema and DNA damage through ROS production as well as photodermatoses. IR is supposed to be involved in melanogenesis throughout the activation of the endothelin receptor B and the mitogen-activated protein kinase, extracellular signal-regulated kinase (ERK)1/2, and protein (p)38. To protect from hyperpigmentation caused by VL, sunscreens containing iron oxides are efficient. The development of systemic antioxidants and new UV-VL sunscreens which allow absorption of the energy in the VL spectrum without reflection may provide further protection. With no existing organic or non-organic filters able to absorb or reflect IR, topical antioxidants may be able to provide some protection against damage caused by IR. However, their clinical efficacy still needs to be confirmed. In conclusion, UV, VL and IR light induce pigmentation. To prevent hyperpigmentation, protection using adequate sunscreens on exposed areas is needed. To date, no efficient protection from IR light exists, but topical antioxidants may be able to provide some protection.
© 2017 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28805937     DOI: 10.1111/jdv.14411

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

1.  Sebocytes contribute to melasma onset.

Authors:  Enrica Flori; Arianna Mastrofrancesco; Sarah Mosca; Monica Ottaviani; Stefania Briganti; Giorgia Cardinali; Angela Filoni; Norma Cameli; Marco Zaccarini; Christos C Zouboulis; Mauro Picardo
Journal:  iScience       Date:  2022-02-04

Review 2.  [Sunscreens of the future: challenges and opportunities].

Authors:  Peter Wolf; Jean Krutmann
Journal:  Hautarzt       Date:  2022-03-08       Impact factor: 0.751

3.  Incobotulinum Toxin Type A for Treatment of Ultraviolet-B-Induced Hyperpigmentation: A Prospective, Randomized, Controlled Trial.

Authors:  Vasanop Vachiramon; Tanaporn Anuntrangsee; Pasita Palakornkitti; Natthachat Jurairattanaporn; Sarawin Harnchoowong
Journal:  Toxins (Basel)       Date:  2022-06-17       Impact factor: 5.075

4.  A novel method for evaluating sun visible light protection factor and pigmentation protection factor of sunscreens.

Authors:  Sérgio Schalka; Marcelo de Paula Corrêa; Leticia Yumi Sawada; Camila C Canale; Thayna N de Andrade
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-08-28

5.  Achillea millefolium L. and Achillea biebersteinii Afan. Hydroglycolic Extracts-Bioactive Ingredients for Cosmetic Use.

Authors:  Katarzyna Gaweł-Bęben; Marcelina Strzępek-Gomółka; Marcin Czop; Zuriyadda Sakipova; Kazimierz Głowniak; Wirginia Kukula-Koch
Journal:  Molecules       Date:  2020-07-24       Impact factor: 4.411

6.  Cistanche deserticola polysaccharide induces melanogenesis in melanocytes and reduces oxidative stress via activating NRF2/HO-1 pathway.

Authors:  Yibo Hu; Jinhua Huang; Yixiao Li; Ling Jiang; Yujie Ouyang; Yumeng Li; Lun Yang; Xiaojiao Zhao; Lihua Huang; Hong Xiang; Jing Chen; Qinghai Zeng
Journal:  J Cell Mol Med       Date:  2020-02-25       Impact factor: 5.310

Review 7.  Traditional Asian Herbs in Skin Whitening: The Current Development and Limitations.

Authors:  Yibo Hu; Hongliang Zeng; Jinhua Huang; Ling Jiang; Jing Chen; Qinghai Zeng
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

8.  Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study.

Authors:  W G Philipp-Dormston; A Vila Echagüe; S H Pérez Damonte; J Riedel; A Filbry; K Warnke; C Lofrano; D Roggenkamp; G Nippel
Journal:  Int J Cosmet Sci       Date:  2020-08       Impact factor: 2.970

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.